SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:995677cd-6523-411c-85ab-f1a4f4a3a910"
 

Search: onr:"swepub:oai:lup.lub.lu.se:995677cd-6523-411c-85ab-f1a4f4a3a910" > PSA-Targeted Alpha-...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Veach, Darren R.Weill Cornell Medical College,Memorial Sloan-Kettering Cancer Center (author)

PSA-Targeted Alpha-, Beta-, and Positron-emitting immunotheranostics in murine prostate cancer models and nonhuman primates

  • Article/chapterEnglish2021

Publisher, publication year, extent ...

  • 2021
  • 11 s.

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:995677cd-6523-411c-85ab-f1a4f4a3a910
  • https://lup.lub.lu.se/record/995677cd-6523-411c-85ab-f1a4f4a3a910URI
  • https://doi.org/10.1158/1078-0432.CCR-20-3614DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • Purpose: Most patients with prostate cancer treated with androgen receptor (AR) signaling inhibitors develop therapeutic resistance due to restoration of AR functionality. Thus, there is a critical need for novel treatment approaches. Here we investigate the theranostic potential of hu5A10, a humanized mAb specifically targeting free PSA (KLK3). Experimental Design: LNCaP-AR (LNCaP with overexpression of wildtype AR) xenografts (NSG mice) and KLK3-Hi- Myc transgenic mice were imaged with 89Zr- or treated with 90Y- or 225Ac-labeled hu5A10; biodistribution and subcellular localization were analyzed by gamma counting, PET, autoradiography, and microscopy. Therapeutic efficacy of [225Ac]hu5A10 and [90Y]hu5A10 in LNCaP-AR tumors was assessed by tumor volume measurements, time to nadir (TTN), time to progression (TTP), and survival. Pharmacokinetics of [89Zr]hu5A10 in nonhuman primates (NHP) were determined using PET. Results: Biodistribution of radiolabeled hu5A10 constructs was comparable in different mouse models. Specific tumor uptake increased over time and correlated with PSA expression. Treatment with [90Y]/[225Ac]hu5A10 effectively reduced tumor burden and prolonged survival (P ≤ 0.0054). Effects of [90Y]hu5A10 were more immediate than [225Ac]hu5A10 (TTN, P < 0.0001) but less sustained (TTP, P < 0.0001). Complete responses were observed in 7 of 18 [225Ac]hu5A10 and 1 of 9 mice [90Y]hu5A10. Pharmacokinetics of [89Zr]hu5A10 were consistent between NHPs and comparable with those in mice. [89Zr]hu5A10-PET visualized the NHP-prostate over the 2-week observation period. Conclusions: We present a complete preclinical evaluation of radiolabeled hu5A10 in mouse prostate cancer models and NHPs, and establish hu5A10 as a new theranostic agent that allows highly specific and effective downstream targeting of AR in PSAexpressing tissue. Our data support the clinical translation of radiolabeled hu5A10 for treating prostate cancer.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Storey, Claire M.University of California, Los Angeles (author)
  • Lückerath, KatharinaUniversity of California, Los Angeles (author)
  • Braun, Katharina (author)
  • Von Bodman, Christian (author)
  • Lamminmäki, UrpoUniversity of Turku (author)
  • Kalidindi, TejaMemorial Sloan-Kettering Cancer Center (author)
  • Strand, Sven ErikLund University,Lunds universitet,Medicinsk strålningsfysik, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Forskningsgruppen för Systemisk strålterapi,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Strålterapi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medical Radiation Physics, Lund,Section V,Department of Clinical Sciences, Lund,Faculty of Medicine,Systemic Radiation Therapy Group,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Radiation therapy,Section I,Department of Clinical Sciences, Lund(Swepub:lu)rafy-ses (author)
  • Strand, JoannaLund University,Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Strålterapi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Radiation therapy,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)jo5371st (author)
  • Altai, MohamedLund University,Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Strålterapi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Radiation therapy,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)mo8753al (author)
  • Damoiseaux, RobertUniversity of California, Los Angeles (author)
  • Zanzonico, PatMemorial Sloan-Kettering Cancer Center (author)
  • Benabdallah, NadiaWashington University in St. Louis (author)
  • Pankov, DmitryMemorial Sloan-Kettering Cancer Center (author)
  • Scher, Howard I.Weill Cornell Medical College,Memorial Sloan-Kettering Cancer Center (author)
  • Scardino, PeterMemorial Sloan-Kettering Cancer Center,Weill Cornell Medical College (author)
  • Larson, Steven M.Memorial Sloan-Kettering Cancer Center,Weill Cornell Medical College (author)
  • Lilja, HansLund University,Lunds universitet,Klinisk kemi, Malmö,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Clinical Chemistry, Malmö,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Memorial Sloan-Kettering Cancer Center(Swepub:lu)klke-hli (author)
  • McDevitt, Michael R.Memorial Sloan-Kettering Cancer Center,Weill Cornell Medical College (author)
  • Thorek, Daniel L.J.Washington University in St. Louis (author)
  • Ulmert, DavidUniversity of California, Los Angeles(Swepub:lu)klke-dul (author)
  • Weill Cornell Medical CollegeMemorial Sloan-Kettering Cancer Center (creator_code:org_t)

Related titles

  • In:Clinical Cancer Research27:7, s. 2050-20601078-0432

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view